Carcinoma, Neuroendocrine - 23 Studies Found Not yet recruiting : Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients : Neuroendocrine Carcinomas : 2015-05-04 : Drug: TLC 388 40 mg/m2 of TLC 388, given as a 30 (+3) minute intravenous infusion, on Days 1, 8 and 15 o Completed : Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3) : Neuroendocrine Carcinoma : 2014-07-24 : Drug: Everolimus , temozolomide Not yet recruiting : Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma : Pulmonary Large Cell Neuroendocrine Carcinoma : 2016-10-22 : Drug: etoposide plus carboplatin Completed : Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma : Neuroendocrine Carcinoma : 2008-01-22 : Drug: Avastin 15 mg/kg By Vein Not yet recruiting : Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer : Neuroendocrine Carcinomas : 2016-06-29 : Drug: Folfiri-bevacizumab Drug: Folfiri Completed : A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas : Gastrointestinal Neuroendocrine Carcinomas : 2014-08-07 : Drug: NAB paclitaxel 100 mg/m2 Completed : Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract : Gastrointestinal Cancer Carcinoma, Neuroendocrine : 2006-07-13 : Drug: Cisplatin Cisplatin 25 m Completed : Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma : Neuroendocrine Carcinoma : 2008-04-18 : Drug: Atiprimod Oral, 14 days on / 14 days off; 30mg capsules Completed : Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma : Neuroendocrine Carcinoma : 2006-10-11 : Drug: Atiprimod oral, 14 days on / 14 days off; 30mg capsules Completed : Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma : Neuroendocrine Carcinoma : 2005-09-12 : Drug: Paclitaxel Drug: Carboplatin Next >>>
